Alternatives to Fluorouracil If You Can't Fill Your Prescription

Fluorouracil (5-FU) is a cornerstone of cancer chemotherapy and dermatologic treatment — but it's been in shortage since 2023. When your pharmacy, cancer center, or dermatologist's office can't get fluorouracil in stock, your care team will need to consider alternatives. The right substitute depends heavily on why you're taking fluorouracil in the first place.

This post covers alternatives for both groups: patients using IV fluorouracil for systemic cancer treatment, and patients using topical fluorouracil cream for skin conditions like actinic keratosis or superficial basal cell carcinoma.

Important: Always Consult Your Doctor Before Switching

Chemotherapy regimens are carefully designed around specific drugs, doses, and schedules. Switching agents is a complex medical decision. Never substitute a cancer medication without explicit guidance from your oncologist or care team. The alternatives listed here are intended to help you have an informed conversation with your provider — not to be acted on independently.

Alternatives to IV Fluorouracil for Cancer Treatment

1. Capecitabine (Xeloda)

Capecitabine is the most common alternative to IV fluorouracil for many cancer types. It is an oral tablet that is absorbed in the gut and enzymatically converted to 5-FU in the body — particularly in tumor tissue. Because it is essentially the same drug once metabolized, it offers similar efficacy to IV 5-FU for many regimens, particularly for colorectal, gastric, and breast cancers.

The major advantages of capecitabine over IV 5-FU are convenience (oral pills at home) and the elimination of central venous catheter (port) requirements for infusion. However, it carries its own risk profile, including hand-foot syndrome, and it interacts significantly with warfarin.

Who it's for: Colorectal, breast, gastric cancer patients who need a 5-FU equivalent.

Key note: Patients with DPD deficiency face the same severe toxicity risk with capecitabine as with fluorouracil.

2. Oxaliplatin (Eloxatin) — Within Combination Regimens

Oxaliplatin is a platinum-based chemotherapy agent frequently used in combination with fluorouracil and leucovorin (FOLFOX regimen). In shortage situations where regimen modification is necessary, your oncologist may adjust the oxaliplatin or irinotecan component, or shift to capecitabine-based equivalents (like CAPOX/XELOX). Oxaliplatin itself is not a standalone replacement for fluorouracil, but it is part of the conversation when regimens must be restructured.

3. Irinotecan — for FOLFIRI-Based Regimens

Irinotecan is a topoisomerase I inhibitor used in the FOLFIRI regimen. If a patient cannot obtain fluorouracil, an oncologist might temporarily switch to an irinotecan-based backbone or modify dosing while supply is restored. This decision is highly context-specific.

Alternatives to Topical Fluorouracil for Skin Conditions

For patients using fluorouracil 0.5%–5% cream for actinic keratosis (AK) or superficial basal cell carcinoma (sBCC), there are several FDA-approved alternatives:

1. Imiquimod (Zyclara, Aldara)

Imiquimod is an immune response modifier cream that stimulates the body's own immune system to attack abnormal skin cells. It is FDA-approved for actinic keratosis (Zyclara 3.75%) and superficial basal cell carcinoma (Aldara 5%). Unlike fluorouracil, imiquimod does not directly kill cells — it activates local immune responses instead. Treatment courses are typically 2–16 weeks depending on the indication and formulation.

2. Tirbanibulin (Klisyri)

Tirbanibulin is a newer topical treatment for actinic keratosis on the face or scalp. It disrupts cell microtubule polymerization and works differently from fluorouracil. One major advantage: the treatment course is only 5 consecutive days — a fraction of the typical 2-4 week fluorouracil course. It has become more widely covered by insurance since its 2020 approval.

3. Diclofenac Sodium Gel (Solaraze)

Diclofenac gel is an NSAID-based topical treatment for actinic keratosis. It is generally better tolerated than fluorouracil with less skin irritation, but is considered less potent. It requires a longer treatment course (typically 60-90 days) and may be appropriate for patients who cannot tolerate more aggressive treatments.

4. Procedural Options for Actinic Keratosis

If topical fluorouracil is unavailable, some patients with actinic keratosis may be candidates for procedural treatments:

Cryotherapy: Liquid nitrogen freezing of individual AK lesions.

Photodynamic therapy (PDT): A photosensitizing agent applied to the skin, then activated by light. Effective for field-directed treatment of multiple AK lesions.

Laser resurfacing: Used in some cases to treat widespread AK fields.

The Bottom Line

Before assuming fluorouracil is unavailable, it's worth exhausting your search options — many patients find it is available if they know where to look. Check our guide to how to find fluorouracil in stock near you. If you truly cannot find it, work with your provider to explore these alternatives based on your specific diagnosis and treatment goals.